Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism.

de Francisco, Angel Luis Martín; Gillespie, Iain Andrew; Gioni, Ioanna; Floege, Jürgen; Kronenberg, Florian; Marcelli, Daniele; Wheeler, David Collins; Froissart, Marc; Drueke, Tilman Bernhard

de Francisco, Angel Luis Martín; Gillespie, Iain Andrew; Gioni, Ioanna; Floege, Jürgen; Kronenberg, Florian; Marcelli, Daniele; Wheeler, David Collins; Froissart, Marc; Drueke, Tilman Bernhard.

Afiliação

de Francisco AL; Servicio de Nefrología, Hospital Universitario Valdecilla, Universidad de Cantabria, Santander, Spain. Electronic address: angelmartindefrancisco@gmail.com.
Gillespie IA; Center for Observational Research (CfOR), Amgen Ltd, Uxbridge, United Kingdom.
Gioni I; On behalf of Amgen Ltd, United Kingdom.
Floege J; Nephrology, RWTH University of Aachen, Aachen, Germany.
Kronenberg F; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
Marcelli D; EMEALA Medical Board, Fresenius Medical Care, Bad Homburg, Germany.
Wheeler DC; Center for Nephrology, Division of Medicine, University College London, United Kingdom.
Froissart M; International Development Nephrology, Amgen Europe GmbH, Zug, Switzerland.
Drueke TB; Inserm U 1088, UFR Médecine/Pharmacie, Université de Picardie, Amiens, France.

Nefrologia ; 36(2): 164-75, 2016.

Article em En | MEDLINE | ID: mdl-26654696

Assuntos

Calcimiméticos/uso terapêutico; Cinacalcete/uso terapêutico; Hiperparatireoidismo Secundário/tratamento farmacológico; Diálise Renal; Cálcio; Humanos; Hormônio Paratireóideo; Estudos Retrospectivos; Resultado do Tratamento

Palavras-chave

Alteraciones del metabolismo oseo-mineral en la enfermedad renal crónica; Chronic kidney disease; Chronic kidney disease-mineral and bone disorder; Enfermedad renal crónica; Haemodialysis; Hemodiálisis; Hiperparatiroidismo secundario; Inicio del tratamiento; Interrupción del tratamiento; Mantenimiento del tratamiento; Secondary hyperparathyroidism; Treatment discontinuation; Treatment initiation; Treatment persistence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diálise Renal / Calcimiméticos / Cinacalcete / Hiperparatireoidismo Secundário Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nefrologia Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google